APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report CVS Health Corporation CVS Jim Cramer Endorses Defensive Investment Case Amid Shrinking Retail Pharmacy Competitive Landscape OPRX OptimizeRx Corporation posts 1206 percent Q4 2025 EPS surprise shares rise modestly in todays trading